Filing Details
- Accession Number:
- 0001127602-20-010224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-11 13:47:25
- Reporting Period:
- 2020-03-10
- Accepted Time:
- 2020-03-11 13:47:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1761920 | T Bryan Baldasare | 3471 River Hills Drive Cincinnati OH 45244 | Exec Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-10 | 1,000 | $6.98 | 51,637 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-10 | 1,000 | $6.96 | 52,637 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
